SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris. Fenizia C, Moltrasio C, Ottobrini L, Utyro O, et al. J Invest Dermatol 2023;143:1601-1604.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fenizia C, Moltrasio C, Ottobrini L, Utyro O, et al. SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris. J Invest Dermatol 2023;143:1601-1604.
PMID: 36716924